• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What We’re Reading: VA Health Benefits Denied; Health Worker Industry Optimism; COVAX Redirecting Vaccine Spending

Article

Black veterans continue to encounter benefits disparities; health workers feel capable of handling future surges after the pandemic; the COVAX initiative aims to redirect remaining vaccine spending

Black Veterans Denied Health Benefits More Than White Veterans

A recent data analysis conducted by the Department of Veterans Affairs (VA) shows that Black veterans applying for physical or mental health benefits were granted assistance at a lower rate than White veterans, according to NBC News. The data, spanning fiscal years 2017 to 2023, showed consistent disparities in benefit approval rates between these groups. As a response to these findings, the VA has established an Agency Equity Team to identify and eliminate any disparities in health care and benefits, aiming to provide equitable treatment to all veterans.

Health Workers Growing Optimistic About Their Industry

In a recent poll, health care workers who experienced significant burnout during the pandemic noted they are beginning to feel more optimistic about the medical profession, according to Axios. The poll revealed that nearly 3 in 5 health care workers are optimistic about the future of the medical industry, and a similar proportion reported being able to handle work-related stressors in the past 6 months. However, although challenges such as staffing shortages persist, there is a growing understanding that addressing these issues is crucial to the industry.

COVAX Plans to Redirect Spending Initiatives for COVID-19 Vaccines

The COVAX initiative, aimed at delivering COVID-19 vaccines to the world's poorest, is contemplating redirecting billions of dollars to prepare for future pandemics or to support vaccine manufacturing in Africa, according to Reuters. With around $2.6 billion left in its funds, COVAX is exploring ways to utilize the remaining money as the emergency phase of the pandemic comes to an end. Options include using the funds for ongoing COVID-19 vaccination programs, booster shots, and wider pandemic preparedness initiatives, as mwell as boosting vaccine manufacturing in Africa to address vaccine shortages for diseases like cholera and yellow fever.

Related Videos
Screenshot of an interview with Adam Colborn, JD
Screenshot of Stephanie Hsia, PharmD
Cesar Davila-Chapa, MD
Screenshot of an interview with Nadine Barrett, PhD
Female doctor in coat with stethoscope on blue background - Pixel-Shot - stock.adobe.com
Io Hui, PhD, researcher at The University of Edinburgh
Corey McEwen, PharmD, MS
Jonathan Kurman, MD
Krunal Patel, MD
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.